Skip to content
healthcare.dev

cevimeline hydrochloride

NDC 0054-0893, cevimeline hydrochloride, capsule, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0893
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091591
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0893 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEVIMELINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
0054-0893-2500054089325100 CAPSULE in 1 BOTTLE (0054-0893-25)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8da082f8-a6a3-46b3-8405-fbc4c220e60b

Use it

Look up 0054-0893 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0893 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0893. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.